In a cohort of DLBCL patients, individuals with combined high MYC and high ST6GALNAC4 expression had strongly decreased overall survival (log-rank P = 0.0031) and increased risk of death (HR = 3.1, 95% CI 1.4 to 6.8) (Fig. 4K). The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.